Programme

5 July 2025 (Saturday)
HKT
Room N101A
Room N101B
Room N102 & 3
  • 09:00
  • 09:10
  • 09:20
  • 09:30
  • 09:40
  • 09:50
  • 10:00
  • 10:10
  • 10:20
  • 10:30
  • 10:40
  • 10:50
  • 11:00
  • 11:10
  • 11:20
  • 11:30
  • 11:40
  • 11:50
  • 12:00
  • 12:10
  • 12:20
  • 12:30
  • 12:40
  • 12:50
  • 13:00
  • 13:10
  • 13:20
  • 13:30
  • 13:40
  • 13:50
  • 14:00
  • 14:10
  • 14:20
  • 14:30
  • 14:40
  • 14:50
  • 15:00
  • 15:10
  • 15:20
  • 15:30
  • 15:40
  • 15:50
  • 16:00
  • 16:10
  • 16:20
  • 16:30
  • 16:40
  • 16:50
  • 17:00
  • 17:10
  • 17:20
  • 17:30
  • 17:40
  • 17:50
  • 18:00
  • 18:10
  • 18:20
Room N101A
Room N101B
  • 09:00-10:30
    09:00-10:30
    State Key Lab Meeting (1): Microbiome and Cancer
    By: Chun-jun Guo, Jennifer ZHANG
  • 10:30-11:00
    10:30-11:00
    Tea Break
  • 11:00-12:30
    11:00-12:30
    State Key Lab Meeting (2): Microbiome/Metabolites, Gut-liver Axis and Liver Diseases
  • 12:30-14:00
    12:30-14:00
    Lunch Symposium (B)
  • 14:00-14:20
    14:00-14:20
    Opening Ceremony
  • 14:20-14:50
    14:20-14:50
    Dr S H Ho Memorial Lecture
    By: Rhonda SOUZA
  • 14:50-15:20
    14:50-15:20
    Joseph Sung Distinguished Lecture
    By: Anna Mae DIEHL
  • 15:20-15:50
    15:20-15:50
    Tea Break
  • 15:50-17:20
    15:50-17:20
    Hepatology Session (1): Viral Hepatitis
    By: Wah-kheong CHAN, Terry YIP, Jimmy LAI
  • 17:20-18:20
    17:20-18:20
    Hepatology Session (2): Metabolic Dysfunction-associated Steatotic Liver Disease
    By: Anna Mae DIEHL, Wah-kheong CHAN
Room N102 & 3
Endoscopy Live Demonstration from Prince of Wales Hospital, Hong Kong (1)
Room N101A
09:00-10:30
09:00
Endoscopy Live Demonstration (1) from Prince of Wales Hospital, Hong Kong
State Key Lab Meeting (1): Microbiome and Cancer
Room N101B
09:00-10:30
09:00
To be confirmed
09:25
Using genetics to explore microbe-host interactions at the molecular level
09:50
Gut microbiome dynamics in MASLD: Implications for liver cancer
10:15
Q & A
GUT-IDDF Young Investigator Award: Oral Presentation I
Room N102 & 3
09:00-10:30
09:00
GUT-IDDF Young Investigator Award: Oral Presentation I
Tea Break
Room N101A
10:30-11:00
10:30
Tea Break
Tea Break
Room N101B
10:30-11:00
10:30
Tea Break
Tea Break
Room N102 & 3
10:30-11:00
10:30
Tea Break
Endoscopy Live Demonstration from Prince of Wales Hospital, Hong Kong (2)
Room N101A
11:00-12:30
11:00
Endoscopy Live Demonstration (2) from Prince of Wales Hospital, Hong Kong
State Key Lab Meeting (2): Microbiome/Metabolites, Gut-liver Axis and Liver Diseases
Room N101B
11:00-12:30
11:00
To be confirmed
GUT-IDDF Young Investigator Award: Oral Presentation II
Room N102 & 3
11:00-12:30
11:00
GUT-IDDF Young Investigator Award: Oral Presentation II
Lunch Symposium (A)
Room N101A
12:30-14:00
12:30
Lunch Symposium (A)
Lunch Symposium (B)
Room N101B
12:30-14:00
12:30
Lunch Symposium
Opening Ceremony
Room N101B
14:00-14:20
14:00
Opening Ceremony
Dr S H Ho Memorial Lecture
Room N101B
14:20-14:50
14:20
The Obesity-GERD connection
Joseph Sung Distinguished Lecture
Room N101B
14:50-15:20
14:50
Morphogens, metabolism and MASLD
Tea Break
Room N101A
15:20-15:50
15:20
Tea Break
Tea Break
Room N101B
15:20-15:50
15:20
Tea Break
IBD Session (1): Advancements in IBD Management
Room N101A
15:50-17:20
15:50
IBD Session (1): Advancements in IBD Management
Hepatology Session (1): Viral Hepatitis
Room N101B
15:50-17:20
15:50
From hepatic steatosis to cancer: The role of metabolism in chronic hepatitis B
16:15
Long-term safety of oral nucleos(t)ide analogues
16:40
The road to 2030: Can Asia achieve viral hepatitis elimination?
17:05
Q & A
JGH-IDDF Case / Video
Room N102 & 3
15:50-18:20
15:50
JGH-IDDF Case / Video
IBD Session (2): Cutting-Edge Issues in IBD: Advances in Imaging and Microbiome Insights
Room N101A
17:20-18:20
17:20
Advancements in perianal crohn's disease management: The role of ultrasound in disease monitoring and treatment efficacy
17:45
Role of gut microbiome in diagnosis and disease characterisation in IBD
18:10
Q & A
Hepatology Session (2): Metabolic Dysfunction-associated Steatotic Liver Disease
Room N101B
17:20-18:20
17:20
Insights from recent omics studies on MASLD pathogenesis and management
17:45
Are incretin therapies the definitive solution for MASH?
18:10
Q & A
** Programme last updated in March 2025